Table 2
| CV risk prevention | Total | DMARD Pt. (n=164) | Biologics Pt (n=67) | P value |
|---|---|---|---|---|
| Age >50 years | Average | 66 | 58 | 0.0001 |
| Male gender | 65 (28%) | 54 | 11 | 0.01 |
| Hypertension | 81 (35%) | 58 (35%) | 23 (34%) | 1.00 |
| Diabetes Mellitus | 19 (8%) | 10 (6%) | 9 (13%) | 0.10 |
| Currently smoking | 40 (17%) | 25 (15%) | 15 (22%) | 0.24 |
| Aspirin therapy | 30 (13%) | 17 (10%) | 13 (19%) | 0.08 |
| Statin therapy | 48 (21%) | 33 (20%) | 15 (22%) | 0.72 |
| TC/HDL Ratio>6 | 4 (2%) | 3 (2%) | 1 (1%) | 1.00 |
| CV risk >20% | 54 (23.3%) | 49 (30%) | 5 (7%) | 0.0001 |